CIK 0001796280 · Non-accelerated filer
Oric Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ORIC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471787157
- Phone
- (650) 388-5600
- Business address
- 240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President and CEO sold 4,336 shares at $8.01 ($34,711)
- 4 Open-market sale President and CEO sold 20,000 shares at $8.03 ($160,562)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Chief Medical Officer sold 2,227 shares at $3.07 ($6,846)
- 4/A Open-market sale Chief Financial Officer sold 2,227 shares at $3.08 ($6,854)
- 4/A Open-market sale President and CEO sold 6,137 shares at $3.07 ($18,859)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 2,089 shares at $3.25 ($6,789)
- 4 Open-market sale Chief Financial Officer sold 2,089 shares at $3.25 ($6,789)
- 4 Open-market sale President and CEO sold 5,764 shares at $3.25 ($18,733)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 9 · 166 filings